New Insights into the Understanding of Mechanisms of Radiation-Induced Heart Disease

Curr Treat Options Oncol. 2023 Jan;24(1):12-29. doi: 10.1007/s11864-022-01041-4. Epub 2023 Jan 4.

Abstract

Cancer patients who receive high-dose thoracic radiotherapy may develop radiation-induced heart disease (RIHD). The clinical presentation of RIHD comprises coronary artery atherosclerosis, valvular disease, pericarditis, cardiomyopathy, and conduction defects. These complications have significantly reduced due to the improved radiotherapy techniques. However, such methods still could not avoid heart radiation exposure. Furthermore, people who received relatively low-dose radiation exposures have exhibited significantly elevated RIHD risks in cohort studies of atomic bomb survivors and occupational exposures. The increased potential in exposure to natural and artificial ionizing radiation sources has emphasized the necessity to understand the development of RIHD. The pathological processes of RIHD include endothelial dysfunction, inflammation, fibrosis, and hypertrophy. The underlying mechanisms may involve the changes in oxidative stress, DNA damage response, telomere erosion, mitochondrial dysfunction, epigenetic regulation, circulation factors, protein post-translational modification, and metabolites. This review will discuss the recent advances in the mechanisms of RIHD at cellular and molecular levels.

Keywords: DNA damage; Mitochondrial dysfunction; Oxidative stress; Radiation-induced heart disease.

Publication types

  • Review

MeSH terms

  • Coronary Artery Disease* / complications
  • Epigenesis, Genetic
  • Heart
  • Heart Diseases* / etiology
  • Humans
  • Radiation Injuries* / diagnosis
  • Radiation Injuries* / etiology